FREE DOWNLOAD ARTICLES : INTERNET RESOURCES HIV AIDS IN CHILDREN

BIBLIOGRAPHY AND INTERNET RESOURCES OF HIV AIDS IN

 CHILDREN

.

BIBLIOGRAPHY

1. Mann, J., D. Tarantola, and T. Netter. 1992. AIDS in the World. Cambridge, MA: Harvard University Press.
2. Schenker, Inon. 2001. “New Challenges for School AIDS Education within an Evolving HIV Pandemic.” Prospects 31, no 3: 415-434.
3. Schenker, Inon, G. Sabar-Friedman, and S. S. Sy. 1996. AIDS Education–Interventions in Multi-Cultural Societies. New York: Plenum Press.
4. World Bank. 2002. Education and HIV/AIDS: A Window of Hope. Washington, DC: World Bank.
5. AAP: Perinatal human immunodeficiency virus testing. Provisional Committee on Pediatric
6. AIDS, American Academy of Pediatrics. Pediatrics 1995 Feb; 95(2): 303-7[Medline].
   Branson BM: Rapid tests for HIV antibody [serial online]. 2000; Available at: http://www.aidsreviews.com%5BFull Text].
7. CDC: Public Health Service Task Force recommendations for the use of antiretroviral drugs in pregnant women infected with HIV-1 for maternal health and for reducing perinatal HIV-1 transmission in the United States. MMWR Recomm Rep 1998 Jan 30; 47(RR-2): 1-30
8. de Martino M, Tovo PA, Balducci M, et al: Reduction in mortality with availability of antiretroviral therapy for children with perinatal HIV-1 infection: Italian Register for HIV Infection in Children and the Italian National AIDS Registry. JAMA 2000 Jul 12; 284(2): 190-7[Medline].
9. International Perinatal HIV Group: The mode of delivery and the risk of vertical transmission of human immunodeficiency virus type 1–a meta-analysis of 15 prospective cohort studies: the International Perinatal HIV Group. N Engl J Med 1999 Apr 1; 340(13): 977-87[Medline].
10. John Hopkins AIDS Service: Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection. Available at: http://hopkins-aids.edu/. 2000.[Full Text].
11. Kovacs JA, Masur H: Prophylaxis against opportunistic infections in patients with human immunodeficiency virus infection. N Engl J Med 2000 May 11; 342(19): 1416-29[Medline].
12. Lindegren ML, Steinberg S, Byers RH Jr: Epidemiology of HIV/AIDS in children. Pediatr Clin North Am 2000 Feb; 47(1): 1-20, v[Medline].
13. Mofenson LM, Lambert JS, Stiehm ER, et al: Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine: Pediatric AIDS Clinical Trials Group Study 185 Team. N Engl J Med 1999 Aug 5; 341(6): 385-93[Medline].
14. Nielsen K: Pediatric HIV infection. HIV Clinical Management. 1999; Available at: http://www.medscape.com/hiv-aidshome%5BFull Text].
15. Pizzo PA, Wilfert CM, eds.: Pediatric AIDS: The challenge of HIV infection in infants, children and adolescents. 3rd ed. Baltimore, Md: Lippincott, Williams & Wilkins; 1998.
16. Ray PE, Rakusan T, Loechelt BJ, et al: Human immunodeficiency virus (HIV)-associated nephropathy in children from the Washington, D.C. area: 12 years’ experience. Semin Nephrol 1998 Jul; 18(4): 396-405[Medline].
17. Rouet F, Sakarovitch C, Msellati P, et al: Pediatric viral human immunodeficiency virus type 1 RNA levels, timing of infection, and disease progression in African HIV-1-infected children. Pediatrics 2003 Oct; 112(4): e289[Medline].
18. World Health Organization. Paediatric HIV and treatment of children living with HIV. Available at http://www.who.int/hiv/paediatric/en/index.html. Accessed 2006.
19. Garrib A, Jaffar S, Knight S, Bradshaw D, Bennish ML. Rates and causes of child mortality in an area of high HIV prevalence in rural South Africa. Tropical Medicine and International Health. Dec 2006;11 (12):1841-1848. [Medline].
20. Chiou CC, Groll AH, Gonzalez CE, Callender D, Venzon D, Pizzo PA, et al. Esophageal candidiasis in pediatric acquired immunodeficiency syndrome: clinical manifestations and risk factors. Pediatr Infect Dis J. Aug 2000;19(8):729-34. [Medline].
21. Brown DM, Jabra-Rizk MA, Falkler WA, Baqui AA, Meiller TF. Identification of Candida dubliniensis in a study of HIV-seropositive pediatric dental patients. Pediatr Dent. May-Jun 2000;22(3):234-8. [Medline].
22. Pongsiriwet S, Iamaroon A, Kanjanavanit S, Pattanaporn K, Krisanaprakornkit S. Oral lesions and dental caries status in perinatally HIV-infected children in Northern Thailand. Int J Paediatr Dent. May 2003;13(3):180-5. [Medline].
23. Tofsky N, Nelson EM, Lopez RN, Catalanotto FA, Fine DH, Katz RV. Dental caries in HIV-infected children versus household peers: two-year findings. Pediatr Dent. May-Jun 2000;22(3):207-14. [Medline].
24. Dias EP, Israel MS, Silva Junior A, Maciel VA, Gagliardi JP, Oliveira RH. Prevalence of oral hairy leukoplakia in 120 pediatric patients infected with HIV-1. Braz Oral Res. Apr-Jun 2006;20(2):103-7. [Medline].
25. Mohle-Boetani JC, Koehler JE, Berger TG, LeBoit PE, Kemper CA, Reingold AL, et al. Bacillary angiomatosis and bacillary peliosis in patients infected with human immunodeficiency virus: clinical characteristics in a case-control study. Clin Infect Dis. May 1996;22(5):794-800. [Medline].
26. Perry RT, Mmiro F, Ndugwa C, Semba RD. Measles infection in HIV-infected African infants. Ann N Y Acad Sci. Nov 2000;918:377-80. [Medline].
27. Enwonwu CO, Falkler WA Jr, Idigbe EO, Savage KO. Noma (cancrum oris): questions and answers. Oral Dis. Apr 1999;5(2):144-9. [Medline].
28. Jaquet D, Levine M, Ortega-Rodriguez E, Faye A, Polak M, Vilmer E, et al. Clinical and metabolic presentation of the lipodystrophic syndrome in HIV-infected children. AIDS. Sep 2000;14(14):2123-8. [Medline].
29. Chiarelli F, Galli L, Verrotti A, di Ricco L, Vierucci A, de Martino M. Thyroid function in children with perinatal human immunodeficiency virus type 1 infection. Thyroid. Jun 2000;10(6):499-505. [Medline].
30. Smith KJ, Skelton HG 3rd, Vogel P, Yeager J, Baxter D, Wagner KF. Exaggerated insect bite reactions in patients positive for HIV. Military Medical Consortium for the Advancement of Retroviral Research. J Am Acad Dermatol. Aug 1993;29(2 Pt 1):269-72. [Medline].
31. Kest H, Brogly S, McSherry G, Dashefsky B, Oleske J, Seage GR. Malignancy in perinatally human immunodeficiency virus-infected children in the United States. Pediatr Infect Dis J. Mar 2005;24(3):237-42. [Medline].
32. Ziegler JL, Katongole-Mbidde E. Kaposi’s sarcoma in childhood: an analysis of 100 cases from Uganda and relationship to HIV infection. Int J Cancer. Jan 17 1996;65(2):200-3. [Medline].
33. Working Group on Antiretroviral Therapy and Medical Management of HIV infected C, Health Resources and Services Administration. Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection. National Institutes of Health. Available at http://aidsinfo.nih.gov/ContentFiles/PediatricGuidelines.pdf. Accessed 2006.
34. Center for Disease Control and Prevention. Guidelines for the use of antiretroviral agents in pediatric HIV infection. MMWR Recomm Rep. Apr 17 1998;47(RR-4):1-43. [Medline].
35. Benjamin DK Jr, Miller WC, Benjamin DK, Ryder RW, Weber DJ, Walter E, et al. A comparison of height and weight velocity as a part of the composite endpoint in pediatric HIV. AIDS. Nov 7 2003;17(16):2331-6. [Medline].
36. Benakappa A, Benakappa N, Benakappa DG. Management of tuberculosis. Indian J Pediatr. Sep-Oct 1995;62(5):557-63. [Medline].
37. Blanche S, Tovo PA. European epidemiology. In: Pizzo PA, Wilfert CM. Pediatric AIDS: The Challenge of HIV Infection in Infants, Children, and Adolescents. 3rd ed. Philadelphia, Pa: Lippincott Williams & Wilkins; 1998:13-22.
38. Bohler T, Wintergerst U, Linde R, Belohradsky BH, Debatin KM. CD95 (APO-1/Fas) expression on naive CD4(+) T cells increases with disease progression in HIV-infected children and adolescents: effect of highly active antiretroviral therapy (HAART). Pediatr Res. Jan 2001;49(1):101-10. [Medline].
39. Capaldini L. Psychosocial issues and psychiatric complications of HIV disease. In: Sande MA, Volberding PA. The Medical Management of AIDS. 6th ed. Philadelphia, Pa: WB Saunders; 1999:241-63.
40. Caselli D, Klersy C, de Martino M, Gabiano C, Galli L, Tovo PA, et al. Human immunodeficiency virus-related cancer in children: incidence and treatment outcome–report of the Italian Register. J Clin Oncol. Nov 15 2000;18(22):3854-61. [Medline].
41. Centers for Disease Control and Prevention. 1994 Revised classification system for human immunodeficiency virusinfection in children less than 13 years of age. MMWR. 1994;43 (No. RR-12):1-10.
42. Centers for Disease Control and Prevention. HIV/AIDS Surveillance Report: HIV Infection and AIDS in the United States and Dependent Areas. Department of Health and Human Services. Available at http://www.cdc.gov/hiv/topics/surveillance/basic.htm.
43. Centers for Disease Control and Prevention. National Center for HIV, STD and TB prevention: Division of HIV/AIDS Prevention. Department of Health and Human Services. Available at http://www.cdc.gov/hiv/dhap.htm. Accessed 2005.
44. Centers for Disease Control and Prevention. 1994 revised guidelines for the performance of CD4+ T-cell determinations in persons with human immunodeficiency virus (HIV) infections. MMWR Recomm Rep. Mar 4 1994;43(RR-3):1-21. [Medline].
45. Chang MW, Orlow SJ. Molluscum contagiosum in children: When and how to treat. Consultant. 1998;1593-1599.
46. Clerici M, Saresella M, Colombo F, Fossati S, Sala N, Bricalli D, et al. T-lymphocyte maturation abnormalities in uninfected newborns and children with vertical exposure to HIV. Blood. Dec 1 2000;96(12):3866-71. [Medline].
47. Cohen H, Chen XC, Sunkle S, Davis L, Geromanos K, Xanthos G, et al. Ability of caregivers to read delayed hypersensitivity skin tests in children exposed to and infected by HIV. The Pediatric Pulmonary and Cardiovascular Complications of Vertically Transmitted HIV Study Group. J Pediatr Health Care. Mar-Apr 2000;14(2):50-5. [Medline].
48. D’Angelo LJ. Sexually transmitted diseases in children and adolescents with HIV infection. In: Pizzo PA, Wilfert CM. Pediatric AIDS: The Challenge of HIV Infection in Infants, Children, and Adolescents. 3rd ed. Philadelphia, Pa: Lippincott Williams & Wilkins; 1998:169-182.
49. Epocrates. Drug Information. Epocrates Online. Available at http://www.epocrates.com/. Accessed 2007.
50. Gondim LA, Zonta RF, Fortkamp E, Schmeling RO. Otorhinolaryngological manifestations in children with human immunodeficiency virus infection. Int J Pediatr Otorhinolaryngol. Aug 31 2000;54(2-3):97-102. [Medline].
51. Greenberg AE, Dabis F, Marum LH. HIV infection in Africa. In: Pizzo PA, Wilfert CM. Pediatric AIDS: The Challenge of HIV Infection in Infants, Children, and Adolescents. 3rd ed. Lippincott Williams & Wilkins; 1998::23-46.
52. Hansen RD, Raja C, Allen BJ. Total body protein in chronic diseases and in aging. Ann N Y Acad Sci. May 2000;904:345-52. [Medline].
53. Hines SE. Primary care for HIV-exposed and infected children: translating progress into practice. Lippincotts Prim Care Pract. Jan-Feb 2000;4(1):43-65. [Medline].
54. Howland LC, Gortmaker SL, Mofenson LM, Spino C, Gardner JD, Gorski H, et al. Effects of negative life events on immune suppression in children and youth infected with human immunodeficiency virus type 1. Pediatrics. Sep 2000;106(3):540-6. [Medline].
55. Joint United Nations Programme on HIV/AIDS. UNAIDS/WHO AIDS Update. Available at www.unaids.org/wad2004/report.html. Accessed 2004.
56. Joint United Nations Programme on HIV/AIDS. UNAIDS/WHO epidemiological fact sheets on HIV/AIDS and Sexually Transmitted Infections, Update, India. Available at www.unaids.org/wad2004/factsheets.html. Accessed 2004.
57. Kline MW. Pediatric HIV Infection. Baylor International Pediatric AIDS Initiative–Educational Resources. 2005.
58. Kovacs A, Scott GB. Advances in the management and care of HIV-positive newborns and infants. In: Pizzo PA, Wilfert CM. Pediatric AIDS: The Challenge of HIV Infection in Infants, Children, and Adolescents. 3rd ed. Philadelphia, Pa: Lippincott Williams & Wilkins; 1998:567-92.
59. Laude TA. Manifestations of HIV disease in children. Clin Dermatol. Jul-Aug 2000;18(4):457-67. [Medline].
60. Layton TL, Davis-McFarland E. Pediatric human immunodeficiency virus and acquired immunodeficiency syndrome: an overview. Semin Speech Lang. 2000;21(1):7-17. [Medline].
61. Leandro-Merhi VA, Vilela MM, Silva MN, Lopez FA, Barros Filho A. Evolution of nutritional status of infants infected with the human immunodeficiency virus. Sao Paulo Med J. Sep 7 2000;118(5):148-53. [Medline].
62. Mastro TD, Zhang KL, Panda S. HIV infection and AIDS in Asia. In: Pizzo PA, Wilfert CM, eds. Pediatric AIDS: The Challenge of HIV Infection in Infants, Children, and Adolescents. 3rd ed. Philadelphia, Pa: Lippincott Williams & Wilkins; 1998:47-63.
    64. McIntosh K. Human immunodeficiency virus: the virus and its pathogenicity. In: Yogev R, Connor E. Management of HIV Infection in Infants and Children. Mosby-Year Book; 1992::35-51.
63. Medical Economics Staff. Physician’s Desk Reference. 55th ed. Montvale, NJ: Medical Economics Company; 2001:472-8, 499-503, 1374-7, 1456-60, 2838-42, 3482-7.
64. Mueller BU. HIV-associated malignancies in children. AIDS Patient Care STDS. Sep 1999;13(9):527-33. [Medline].
65. Naidoo S, Chikte U. Oro-facial manifestations in paediatric HIV: a comparative study of institutionalized and hospital outpatients. Oral Dis. Jan 2004;10(1):13-8. [Medline].
66. National Institutes of Health, National Institue of Allergy and Infectious Disease, US Dept of Health and Human Services. HIV Infection in Minority Populations. 2005;[Full Text].
67. Ndour M, Sow PS, Coll-Seck AM, Badiane S, Ndour CT, Diakhate N, et al. AIDS caused by HIV1 and HIV2 infection: are there clinical differences? Results of AIDS surveillance 1986-97 at Fann Hospital in Dakar, Senegal. Trop Med Int Health. Oct; 2000;5(10):687-91. [Medline].
68. Padhani DH, Manji KP, Mtanda AT. Ocular manifestations in children with HIV infection in Dar es Salaam, Tanzania. J Trop Pediatr. Jun 2000;46(3):145-8. [Medline].
69. Penneys NS, ed. Bacterial and complex infections. In: Skin Manifestations of AIDS. 2nd ed. St Louis, Mo: Mosby-Year Book; 1995:50-74.
70. Portela MB, Souza IP, Costa EM, Hagler AN, Soares RM, Santos AL. Differential recovery of Candida species from subgingival sites in human immunodeficiency virus-positive and healthy children from Rio de Janeiro, Brazil. J Clin Microbiol. Dec 2004;42(12):5925-7. [Medline].
71. Raju PV, Rao GR, Ramani TV, Vandana S. Skin disease: clinical indicator of immune status in human immunodeficiency virus (HIV) infection. Int J Dermatol. Aug; 2005;44(8):646-9. [Medline].
72. Ramos-Gomez F. Dental considerations for the paediatric AIDS/HIV patient. Oral Dis. 2002;8 Suppl 2:49-54. [Medline].
73. Rogers MF, Lindegren ML, Simonds RJ. Pediatric HIV infection in the United States. In: Pizzo PA, Wilfert CM,. Pediatric AIDS: The Challenge of HIV Infection in Infants, Children, and Adolescents. 3rd ed. Philadelphia, Pa: Lippincott Williams & Wilkins; 1998:3-11.
74. Rongkavilit C, Mitchell CD, Nachman S. Varicella zoster infection in HIV-infected children. Paediatr Drugs. Jul-Aug 2000;2(4):291-7. [Medline].
75. Shearer WT, Easley KA, Goldfarb J, Jenson HB, Rosenblatt HM, Kovacs A, et al. Evaluation of immune survival factors in pediatric HIV-1 infection. Ann N Y Acad Sci. Nov 2000;918:298-312. [Medline].
76. Smith R, Malee K, Charurat M, Magder L, Mellins C, Macmillan C, et al. Timing of perinatal human immunodeficiency virus type 1 infection and rate of neurodevelopment. The Women and Infant Transmission Study Group. Pediatr Infect Dis J. Sep 2000;19(9):862-71. [Medline].
77. Solomon BA, Laude TA. A peculiar annular eruption in a child with AIDS. J Am Acad Dermatol. Sep 1995;33(3):513-4. [Medline].
78. Stefanaki C, Stratigos AJ, Stratigos JD. Skin manifestations of HIV-1 infection in children. Clin Dermatol. Jan-Feb 2002;20(1):74-86. [Medline].
79. Straka BF, Whitaker DL, Morrison SH, Oleske JM, Grant-Kels JM. Cutaneous manifestations of the acquired immunodeficiency syndrome in children. J Am Acad Dermatol. May 1988;18(5 Pt 1):1089-102. [Medline].
80. Taha TE, Nour S, Kumwenda NI, Broadhead RL, Fiscus SA, Kafulafula G, et al. Gender differences in perinatal HIV acquisition among African infants. Pediatrics. Feb 2005;115(2):e167-72. [Medline].
81. Thomas P, Bornschlegel K, Singh TP, Abrams EJ, Cervia J, Fikrig S, et al. Tuberculosis in human immunodeficiency virus-infected and human immunodeficiency virus-exposed children in New York City. The New York City Pediatric Spectrum of HIV Disease Consortium. Pediatr Infect Dis J. Aug 2000;19(8):700-6. [Medline].
82. UNAIDS, UNICEF, USAID. Children on the Brink 2004: A joint report of new orphan estimates and a framework for action. UNICEF. Available at http://www.unicef.org/publications/index_22212.html. Accessed 2004.
83. UNAIDS, WHO. UNAIDS/WHO AIDS Epidemic Update:. UNAIDS. Available at http://www.unaids.org/en/HIV_data/epi2006/default.asp. Accessed 2006.
84. von Seidlein L, Gillette SG, Bryson Y, Frederick T, Mascola L, Church J, et al. Frequent recurrence and persistence of varicella-zoster virus infections in children infected with human immunodeficiency virus type 1. J Pediatr. Jan 1996;128(1):52-7. [Medline].
85. Weedon D, ed. The spongiotic reaction pattern. In: Skin Pathology. New York, NY: Churchill Livingstone; 1997:83-107.
86. Weedon D, ed. Mycoses and algal infections. In: Skin Pathology. New York, NY: Churchill Livingstone; 1997:555-582.
87. Weedon D, ed. Vascular tumors. In: Skin Pathology. New York, NY: Churchill Livingstone; 1997:821-854.
88. Whitworth JM, Janniger CK, Oleske JM, Schwartz RA. Cutaneous manifestations of childhood acquired immunodeficiency syndrome and human immunodeficiency virus infection. Cutis. Feb 1995;55(2):62-6, 70-2. [Medline].
89. Working Group on Antiretroviral Therapy and Medical Management of HIV-Infected Children. Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infectioin. Developed by Working Group on Antiretroviral Therapy and Medical Management of HIV-Infected Children. National Institutes of Health. Available at http://aidsinfo.nih.gov/. Accessed 2005.
90. World Health Organization. The World Health Report: Global Health–today’s challenges. Available at http://www.who.int/whr/2003/en/Chapter1.pdf. Accessed 2005.

INTERNET RESOURCES

• Early virological suppression with three-class antiretroviral therapy in HIV-infected African infants. Lippincott Williams & Wilkins. July 11, 2008.
• Child survival gains in Tanzania: analysis of data from demographic and health surveys Elsevier. April 12, 2008.
• Utilization of a basic care and prevention package by HIV-infected persons in Uganda. Routledge. February 2008.
• Invasive pneumococcal disease in an underimmunized, high HIV prevalence population Elsevier. January 10, 2008.
• The evidence for using conjugate vaccines to protect HIV-infected children against pneumococcal disease January 2008.
• Reasons for delay in initiation of antiretroviral therapy in a population of HIV-infected South African children Oxford University Press. December 2007.
• Immune reconstitution in human immunodeficiency virus type 1-infected children with different virological responses to anti-retroviral therapy. Blackwell Publishing. December 2007.
• UCSF Institute for Global Health – Literature Digest UCSF Center for HIV Information. October 2007.
• What Strategies to Boost Production of Affordable Fixed-Dose Anti-Retroviral Drug Combinations for Children in the Developing World? Bentham Science Publishers Ltd. March 2007.
• CD4 percentages and total lymphocyte counts as early surrogate markers for pediatric HIV-1 infection in resource-limited settings Oxford University Press. October 2006.
• Evaluation of p24-based antiretroviral treatment monitoring in pediatric HIV-1 infection: prediction of the CD4+ T-cell changes between consecutive visits Lippincott Williams & Wilkins. April 15, 2006.
• Invasive pneumococcal disease among infants before and after introduction of pneumococcal conjugate vaccine American Medical Association. April 12, 2006.
• Mortality in HIV-infected and uninfected children of HIV-infected and uninfected mothers in rural Uganda Lippincott Williams & Wilkins. April 01, 2006.
• Evaluation of HIV-1 p24 antigenemia and level of CD8+CD38+ T cells as surrogate markers of HIV-1 RNA viral load in HIV-1-infected patients in Dakar, Senegal Lippincott Williams & Wilkins. April 01, 2006.
• Complementary feeding adequacy in relation to nutritional status among early weaned breastfed children who are born to HIV-infected mothers: ANRS 1201/1202 Ditrame Plus, Abidjan, Cote d’Ivoire American Academy of Pediatrics Journals. April 2006.
• Health, neurologic, and cognitive status of HIV-infected, long-surviving, and antiretroviral-naive Ugandan children American Academy of Pediatrics Journals. March 2006.
• Incidence of clinically significant bacteraemia in children who present to hospital in Kenya: community-based observational study Elsevier. February 11, 2006.
• Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis Massachusetts Medical Society. January 05, 2006.
• Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine Massachusetts Medical Society. January 05, 2006.
• Hypertriglyceridemia and hypercholesterolemia in human immunodeficiency virus-1-infected children treated with protease inhibitors Elsevier. January 2006.
• Estimating the net effect of HIV on child mortality in African populations affected by generalized HIV epidemics Lippincott Williams & Wilkins. February 01, 2005.
• Challenges and hope for the diagnosis of tuberculosis in infants and young children Elsevier. January 08, 2005.
• Induced sputum versus gastric lavage for microbiological confirmation of pulmonary tuberculosis in infants and young children: a prospective study Elsevier. January 08, 2005.
• Bacteremia among children admitted to a rural hospital in Kenya Massachusetts Medical Society. January 06, 2005.
• Comparison of atovaquone and azithromycin with trimethoprim-sulfamethoxazole for the prevention of serious bacterial infections in children with HIV infection Infectious Diseases Society of America. January 01, 2005.
• Human resources for health: overcoming the crisis Elsevier. December 03, 2004.
• Mortality of infected and uninfected infants born to HIV-infected mothers in Africa: a pooled analysis Ghent International AIDS Society Working Group on HIV in Women and Children, Elsevier. October 02, 2004.
• Child mortality and HIV infection in Africa: a review Lippincott Williams & Wilkins. June 2004.
• HIV post-exposure prophylaxis for child rape survivors in KwaZulu-Natal, South Africa: Who qualifies and who complies? Elsevier. April 2008.
• The cost-effectiveness of cotrimoxazole prophylaxis in HIV-infected children in Zambia Lippincott Williams & Wilkins. March 30, 2008.
• Current and future antiretroviral treatment options in paediatric HIV infection 2008.
  UCSF Institute for Global Health – Literature Digest UCSF Center for HIV Information. October 2007.
• What Strategies to Boost Production of Affordable Fixed-Dose Anti-Retroviral Drug Combinations for Children in the Developing World? Bentham Science Publishers Ltd. March 2007.
• Reduction in Preterm Delivery and Neonatal Mortality after the Introduction of Antenatal Cotrimoxazole Prophylaxis among HIV-Infected Women with Low CD4 Cell Counts University of Chicago Press. December 01, 2006.
• CD4 percentages and total lymphocyte counts as early surrogate markers for pediatric HIV-1 infection in resource-limited settings Oxford University Press. October 2006.
• Evaluation of p24-based antiretroviral treatment monitoring in pediatric HIV-1 infection: prediction of the CD4+ T-cell changes between consecutive visits Lippincott Williams & Wilkins. April 15, 2006.
• Primary HIV drug resistance and efficacy of first-line antiretroviral therapy guided by resistance testing Lippincott Williams & Wilkins. April 15, 2006.
• Safe treatment interruptions in patients with nadir CD4 counts of more than 350 cells/microL: a randomized trial Lippincott Williams & Wilkins. April 01, 2006.
• Neurologic Complications of HIV Disease and their Treatments International AIDS Society-USA. April 2006.
• Health, neurologic, and cognitive status of HIV-infected, long-surviving, and antiretroviral-naive Ugandan children American Academy of Pediatrics Journals. March 2006.
• Partial treatment interruption of protease inhibitor-based highly active antiretroviral therapy regimens in HIV-infected children Lippincott Williams & Wilkins. March 2006.
• Failure to eradicate HIV despite fully successful HAART initiated in the first days of life Elsevier. March 2006.
• Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis Massachusetts Medical Society. January 05, 2006.
• Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine Massachusetts Medical Society. January 05, 2006.
• Deaths in the era of HAART: contribution of late presentation, treatment exposure, resistance and abnormal laboratory markers Lippincott Williams & Wilkins. January 02, 2006.
• Hypertriglyceridemia and hypercholesterolemia in human immunodeficiency virus-1-infected children treated with protease inhibitors Elsevier. January 2006.
• Piloting post-exposure prophylaxis in Kenya raises specific concerns for the management of childhood rape Elsevier. January 2006.
• A new model to monitor the virological efficacy of antiretroviral treatment in resource-poor countries Elsevier. January 2006.
• Dried blood spots improve access to HIV diagnosis and care for infants in low-resource settings Lippincott Williams & Wilkins. April 15, 2005.
• Trends in Antiretroviral Therapy Use and Survival Rates for a Large Cohort of HIV-Infected Children and Adolescents in the United States, 1989-2001 Lippincott Williams & Wilkins. April 01, 2005.
• Incidence and prevalence of HIV encephalopathy in children with HIV infection receiving highly active anti-retroviral therapy (HAART) American Academy of Pediatrics Journals. March 2005.
• Sustained viral suppression and immune recovery in HIV type 1-infected children after 4 years of highly active antiretroviral therapy University of Chicago Press. February 15, 2005.
• Pediatric Diagnosis and Monitoring Working Group Forum for Collaborative HIV Research. February 2005.
• Facilitating adherence to highly active antiretroviral therapy in children with HIV infection: what are the issues and what can be done? Adis International. 2005.
• Changes in Total Lymphocyte Count as a Surrogate for Changes in CD4 Count Following Initiation of HAART: Implications for Monitoring in Resource-Limited Settings Lippincott Williams & Wilkins. August 20, 2004.
• Delayed onset of pubertal development in children and adolescents with perinatally acquired HIV infection Lippincott Williams & Wilkins. April 01, 2003.
• Height, weight, and growth in children born to mothers with HIV-1 infection in Europe American Academy of Pediatrics Journals. January 2003.
• Lack of evidence of mitochondrial dysfunction in the offspring of HIV infected women: retrospective review of perinatal exposure to antiretroviral drugs in the Perinatal AIDS Collaborative Transmission Study New York Academy of Sciences. November 2000.
• Maternal viral load and rate of disease progression among vertically HIV-1-infected children: an international meta-analysis Lippincott Williams & Wilkins. January 02, 2004.
• The impact of HIV on mortality during in-patient rehabilitation of severely malnourished children in Malawi Elsevier. July 2008.
• Association of Hypercholesterolemia Incidence With Antiretroviral Treatment, Including Protease Inhibitors, Among Perinatally HIV-Infected Children Lippincott Williams & Wilkins. April 15, 2008.
• Long-Term Safety and Effectiveness of Ritonavir, Nelfinavir, and Lopinavir/Ritonavir in Antiretroviral-Experienced HIV-Infected Children Lippincott Williams & Wilkins. March 27, 2008.
• Severe anemia in Malawian children Massachusetts Medical Society. February 28, 2008.
  Optimizing paediatric HIV care in Kenya: challenges in early infant diagnosis World Health Organization. February 2008.
• UCSF Institute for Global Health – Literature Digest UCSF Center for HIV Information. October 2007.
• Psychosocial support and marginalization of youth-headed households in Rwanda Taylor & Francis Group. April 2006.
• Incidence and prevalence of HIV encephalopathy in children with HIV infection receiving highly active anti-retroviral therapy (HAART) American Academy of Pediatrics Journals. March 2005.
• Induced sputum versus gastric lavage for microbiological confirmation of pulmonary tuberculosis in infants and young children: a prospective study Elsevier. January 08, 2005.
• Challenges and hope for the diagnosis of tuberculosis in infants and young children Elsevier. January 08, 2005.
• A comparison of height and weight velocity as a part of the composite endpoint in pediatric HIV Lippincott Williams & Wilkins. November 07, 2003.
• Delayed onset of pubertal development in children and adolescents with perinatally acquired HIV infection Lippincott Williams & Wilkins. April 01, 2003.
• Height, weight, and growth in children born to mothers with HIV-1 infection in Europe American Academy of Pediatrics Journals. January 2003.
• Centers for Disease Control. “Division of HIV/AIDS Prevention.” Available from www.cdc.gov/hiv/dhap.htm.
• Elizabeth Glaser Pediatric AIDS Foundation. Available from http://www.pedaids.org/.
  Joint United Nations Program on HIV/AIDS. Available from http://www.unaids.org/.
  The Body. “An AIDS andHIV/AIDS in pregnancy and newborn
• Australia – Canada – Germany – Hong Kong – International – New Zealand – South Africa
  United Kingdom – United States of America – WHO – Articles in journals – {Related topics}
  Australia
• NSW Health
• HIV Testing in Pregnancy: Information for Health Care Workers [2004]
  Canada
• Alberta Health and Wellness
• Prenatal HIV: Public Health Guidelines [2008]
• Canadian HIV Trials Network
• Canadian consensus guidelines for the management of pregnancy, labour and delivery and for postpartum care in HIV-positive pregnant women and their offspring (summary of 2002 guidelines) [2003]
• Canadian consensus guidelines for the care of HIV-positive pregnant women: putting recommendations into practice [2003]
• Canadian Paediatric Society
• Testing for HIV infection in pregnancy [2008]
• Evaluation and treatment of the human immunodeficiency virus-1-exposed infant [2004]
• Public Health Agency of Canada
• Guiding principles for human immunodeficiency virus (HIV) testing of women during pregnancy – 2002 [2002]
• Society of Obstetricians and Gynaecologists of Canada
• Mode of delivery for pregnant women infected by the human immunodeficiency virus [2001]
• Germany
• Deutsche AIDS-Gesellschaft
• German-Austrian Recommendations for HIV Therapy in Pregnancy and in HIV Exposed Newborn – Update 2005 [2005]
• Diagnostics and treatment of HIV-discordant couples who wish to have children [2004]
  Hong Kong
• Hong Kong College of Obstetricians and Gynaecologists
• Guidelines for HIV Testing in Pregnancy [2001]
  International
• Cochrane Library
• Efficacy and safety of cesarean delivery for prevention of mother-to-child transmission of HIV-1 [2008]
• Global Health Council
• Vitamin A supplementation in pregnancy does not reduce mother-to-child transmission of HIV [2002]
• Pathfinder International
  Integrating Prevention of Mother-to-Child HIV Transmission into Existing Maternal, Child, and Reproductive Health Programs [2003]
• UNAIDS: The Joint UN Programme on HIV/AIDS
• Prevention of mother-to-child transmission of HIV [Collection of guidelines]
• United Nations Children’s Fund – UNICEF
• Mother-to-Child Transmission of HIV [2002]
• United Nations Population Division
• HIV/AIDS and Fertility in Sub-Saharan Africa: A Review of the Research Literature [2002]
• United Nations Population Fund
• Guidance on Global Scale-Up of the Prevention of Mother-to-Child Transmission of HIV [2007]
• HIV Prevention in Maternal Health Services: Programming Guide [2004]
  New Zealand
• Auckland District Health Board
• Guidelines for Paediatric Management of Infants Born to HIV+ Pregnant Women [2007]
• New Zealand College of Midwives
  HIV Screening [2006]
  South Africa
• Maternal Care Manual – Perinatal Education Programme
• Screening tests for HIV [2006]
  United Kingdom
• British HIV Association
• British HIV Association and Children’s HIV Association guidelines for the management of HIV infection in pregnant women 2008 [2008]
• Pregnancy (2005) [2005]
• Royal College of Obstetricians and Gynaecologists
• National Study of HIV in Pregnancy & Childhood [2005]
• Management of HIV in Pregnancy [2004]
• UK National Screening Committee
  HIV screening [2006]
  United States of America
• AIDSinfo
• Perinatal Guidelines [Collection of guidelines]
• Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-Infected Women for
• Maternal Health and Interventions to Reduce Perinatal HIV-1 Transmission in the United States [2006]
• American Academy of Pediatrics
• Evaluation and Treatment of the Human Immunodeficiency Virus-1–Exposed Infant [2004]
• Surveillance of Pediatric HIV Infection [1998]
• American College of Obstetricians and Gynecologists
  Human Immunodeficiency Virus [2007]
• American Psychiatric Association
• HIV infection and pregnant women [2003]
• Body: An AIDS and HIV Information Resource
• HIV and Pregnancy [Collection of guidelines]
  CDC HIV/AIDS
• Pregnancy and Childbirth [Collection of guidelines]
• Center for Health and Gender Equity
• Fulfilling Reproductive Rights for Women Affected by HIV: A Tool for Monitoring Achievement of Millennium Development Goals [2004]
• Centers for Disease Control and Prevention
• Prenatal HIV Testing and Antiretroviral Prophylaxis at an Urban Hospital — Atlanta, Georgia, 1997–2000 [2004]
• Rapid Point-of-Care Testing for HIV-1 During Labor and Delivery — Chicago, Illinois, 2002 [2003]
• Progress Toward Elimination of Perinatal HIV Infection — Michigan, 1993–2000 [2002]
• Revised Recommendations for HIV Screening of Pregnant Women [2001]
  Madigan Army Medical Center
• Perinatal HIV Referral Guidelines [2006]
• National Guideline Clearinghouse
• Public Health Service Task Force recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States. Centers for Disease Control and Prevention [2008]
• Medical care of HIV-infected substance-using women. New York State Department of Health [2005]
• Management of HIV in pregnancy. Royal College of Obstetricians and Gynaecologists [2004]
• Evaluation and treatment of the human immunodeficiency virus-1–exposed infant. American Academy of Pediatrics [2004]
• National Institute of Child Health and Human Development
  AIDS/HIV [Collection of guidelines]
• NICU-Web – University of Washington
• Recommended Guidelines for Management of the HIV-1 Exposed Infant [2002]
  RAND
• Preventing Perinatal Transmission of HIV [2003]
• U.S. Agency for International Development
• Prevention of Mother-to-Child Transmission of HIV [2005]
• University of Michigan Evidence-Based Pediatrics
  Long and Short Prenatal and Postnatal Zidovudine Treatment Courses Are Comparable [2000]
• Elective C-Section Reduces Vertical HIV Transmission [1999]
  Washington State Department of Health
• Screening and Management of Maternal HIV Infection: Implications for Mother and Infant [2003]
• Women, Children, and HIV
• Women, Children, and HIV [Collection of guidelines]
  WHO
• WHO Reproductive Health Library
• Vaginal disinfection during labour for reducing the risk of mother-to-child transmission of HIV infection [2006]
• Antiretroviral therapy for reducing the risk of mother-to-child transmission [2006]
• World Health Organization
• Technical consultation on the integration of HIV interventions into maternal, newborn and child health services [2008]
• Linkages between sexual and reproductive health (SRH) and HIV [2007]
• Guidance on global scale-up of the prevention of mother to child transmission of HIV : towards universal access for women, infants and young children and eliminating HIV and AIDS among children [2007]
• Antiretroviral drugs for treating pregnant women and preventing HIV infection in infants: towards universal access [2006]
• Antiretroviral Drugs for Treating Pregnant Women and Preventing HIV Infection in
• Children: Guidelines for Women Living with HIV/AIDS and Their Children in Resource-Constrained Settings [2004]
• HIV-infected women and their families: Psychosocial support and related issues [2003]
  New data on the prevention of mother-to-child transmission of HIV and their policy implications [2001]
• Anti-Retroviral Regimens for the Prevention of Mother-to-Child HIV-1 Transmission: the Programmatic Implications [2000]
• HIV in pregnancy: A review [1999]
  Articles in journals
• American Family Physician
• Management of Newborns Exposed to Maternal HIV Infection [2002]
• Obstetric Care in Patients with HIV Disease [2001]
• American Journal of Clinical Nutrition
• Micronutrients and vertical transmission of HIV-1 [2002]
• Archives of Disease in Childhood
• Advances in the prevention and treatment of paediatric HIV infection in the United Kingdom [2002]
• British Medical Journal
  Monitoring and evaluation of programmes to prevent mother to child transmission of HIV in Africa [2007]
• HIV and pregnancy [2007]
• What can we do to reduce mother to child transmission of HIV? [2002]
• Role of traditional birth attendants in preventing perinatal transmission of HIV [2002]
• Bulletin of the World Health Organization
• Prevention and Treatment of Human Immunodeficiency Virus/Acquired
• Immunodeficiency Syndrome in Resource-Limited Settings [2005]
• Reconsidering empirical cotrimoxazole prophylaxis for infants exposed to HIV infection [2004]
• Rates, barriers and outcomes of HIV serostatus disclosure among women in developing countries: implications for prevention of mother-to-child transmission programmes [2004]
• Prevention of mother-to-child transmission of HIV: challenges for the current decade [2001]
• Canadian Family Physician
• When pregnant women are not screened for HIV [2007]
• Antiretroviral treatment of maternal HIV infection [2004]
• Canadian Medical Association Journal
• Opt in or opt out: What is optimal for prenatal screening for HIV infection? [2003]
• Failure to prevent perinatal HIV infection [2002]
• Routine prenatal screening for HIV in a low-prevalence setting [1998]
• Evidence-based guidelines for universal counselling and offering of HIV testing in pregnancy in Canada [1998]
• Health Policy and Planning
• Prevention of mother-to-child transmission of HIV in developing countries: recommendations for practice. The Ghent International Working Group on Mother-To
• Child Transmission of HIV [2000]
• Hong Kong Medical Journal
• Universal antenatal human immunodeficiency virus testing in Hong Kong: consensus statement [2002]
• Journal of Antimicrobial Chemotherapy
• Prevention of perinatal HIV transmission during pregnancy [2000]
• Medical Journal of Australia
• The evidence for a change in antenatal HIV screening policy in Australia [2006]
• The time to recommend antenatal HIV screening for all pregnant women has arrived [2004]
• Memórias do Instituto Oswaldo Cruz
• Vertical human immunodeficiency virus type 1–HIV-1–transmission–a review [2001]
  Revista do Hospital das Clinicas
• HIV-1: maternal prognosis [2004]
• Topics in HIV Medicine
• Preconception health care for HIV-infected women [2007]
• Prevention of Mother-to-Child Transmission of HIV in Africa [2004]
• Guidelines
• Neonatal infections
• Infections in pregnancy
• HIV/AIDS in children and adolescents
• HIV/AIDS and breastfeeding/infant feeding
• HIV/AIDS HIV Information Resource.” Available from http://www.thebody.com/.

 

Supported  by
FIGHT AGAINTS AIDS, SAVE INDONESIAN CHILDRENS

Yudhasmara Foundation

Working together against HIV and Aids in Indonesia, Save our Children From HIV-AIDS

 

Office ; JL Taman Bendungan Asahan 5 Jakarta Indonesia 10210

phone : 62(021) 70081995 – 5703646

email : judarwanto@gmail.com,

https://childrenhivaids.wordpress.com/

 

 

 

Editor in Chief :

Dr WIDODO JUDARWANTO

phone : 62(021) 70081995 – 62(021) 5703646, mobile : 0817171764

email : judarwanto@gmail.com

 

 

Copyright © 2009, Fight Against Aids, Save Indonesian Childrens Information Education Network. All rights reserved.

Advertisements